Quantitative evaluation of common polymorphism (rs1801282) in the PPARγ2 gene and hypertension susceptibility

Gene
Yujun Wang, Chibo Liu

Abstract

The peroxisome proliferator-activated receptor-γ2 (PPARγ2) gene has been implicated in the etiology of hypertension. However, the results have been inconsistent. In this study, a meta-analysis was performed to assess the association of PPARγ2 rs1801282 polymorphism with hypertension risk. Published literature from PubMed, Embase databases, CNKI and Wanfang Data were retrieved. Pooled odds ratio (OR) with 95% confidence interval (CI) was calculated using fixed- or random-effects model. Eight studies (1865 cases and 1416 controls) for rs1801282 polymorphism were identified. The results suggested that rs1801282 polymorphism Ala allele might be protective for hypertension among East Asians (Ala/Ala+Pro/Ala vs. Pro/Pro: OR=0.63, 95%CI 0.46-0.86) but not among Caucasians (Ala/Ala+Pro/Ala vs. Pro/Pro: OR=0.72, 95%CI 0.38-1.38). The results indicated the significant association of PPARγ2 rs1801282 polymorphism with hypertension susceptibility among East Asians.

References

Sep 1, 1986·Controlled Clinical Trials·R DerSimonian, N Laird
Jan 1, 1993·The American Journal of Medicine·T W Kurtz, M A Spence
Oct 6, 1997·BMJ : British Medical Journal·M EggerC Minder
Nov 27, 2004·Diabetes Research and Clinical Practice·Mayumi HorikiToshio Ogihara
Jun 24, 2005·American Journal of Epidemiology·Valentina ParacchiniEmanuela Taioli
Dec 20, 2005·Cell·Michael Lehrke, Mitchell A Lazar
Oct 31, 2008·Current Hypertension Reports·Michael HarrisonUlrich Broeckel
May 12, 2009·Nature Genetics·Daniel LevyCornelia M van Duijn
May 12, 2009·Nature Genetics·Christopher Newton-ChehPatricia B Munroe

❮ Previous
Next ❯

Citations

Jan 18, 2019·Journal of Obesity·Ana Paula Dos Santos RodriguesErika Aparecida Silveira
Oct 3, 2018·Aging and Disease·Szkup MałgorzataGrochans Elżbieta

❮ Previous
Next ❯

Related Concepts

Related Feeds

CV Disorders & Type 2 Diabetes

This feed focuses on the association of cardiovascular diseases in patients with type 2 diabetes.